BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: TNF-like weak inducer of apoptosis receptor (TWEAKR; TNFRSF12A; FN14)

October 8, 2015 7:00 AM UTC

Mouse studies suggest anti-TWEAKR antibodies could help treat cancer-induced cachexia. In mice with syngeneic tumors expressing human TWEAKR, an anti-TWEAKR antibody decreased tumor-induced weight los...